Continued research at the molecular level has elucidated that the epigenetic modification of the MGMT gene, specifically the hypermethylation of its promoter region, is instrumental in augmenting the sensitivity of tumor cells to alkylating agents. This evidence concerns the gene MGMT and neoplasm.